Stage II Ovarian Cancer: Elizabeth's Survivor Story

Patient Info: Elizabeth Jardinella, Female, Under 40 | Stage II

Cancer-free for about 2 years, with surveillance scans continuing to show no evidence of disease while she takes maintenance letrozole.

MD AndersonRead more →

Early-stage ovarian squamous cell carcinoma arising in a mature cystic teratoma

Patient Info: Anonymized, female, 50s | Stage I

Biomarkers: ovarian tumor HPV DNA-negative; p16-negative

She achieved complete remission and had no evidence of recurrence 24 months after surgery, at follow-up in June 2026.

PubMed CentralRead more →

Stage III MSI-High Colorectal Adenocarcinoma: Briana's Survivor Story

Patient Info: Briana Ghbein, Under 40 | Stage III

Biomarkers: MSH2 mutation, dMMR/MSI-H

Postoperative pathology after her 2024 treatment showed no evidence of disease.

Fight Colorectal CancerRead more →

Stage IV Colorectal Cancer: Jackie's Patient Story

Patient Info: Jackie, Female | Stage IV

Biomarkers: Lynch syndrome

Metastatic Site: Not reported

Jackie’s Stage IIIB rectal cancer later recurred as Stage IV/metastatic disease, but early immunotherapy response was strong, with no visible tumor on MD Anderson sigmoid scope about 6 weeks after starting treatment.

The Patient StoryRead more →

Stage II Invasive Ductal Carcinoma: Monica's Survivor Story

Patient Info: Monica, Female, Under 40 | Stage II

As of June 2026, Monica described survivorship after treatment for Stage IIB breast cancer and a separate undifferentiated pleomorphic sarcoma, with lasting neuropathy, bone pain, reconstruction complications, and grief around fertility.

The Patient StoryRead more →

Stage III Triple-Negative Breast Cancer: Stephanie's Survivor Story

Patient Info: Stephanie, Female | Stage III

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1 mutation

As of June 2026, Stephanie described being a 10-year survivor after Stage III BRCA1-positive triple-negative breast cancer, with remission shown after chemotherapy and no recurrence described.

The Patient StoryRead more →

Stage II HR-Positive Invasive Ductal Carcinoma: Callie's Survivor Story

Patient Info: Callie, Female, Under 40 | Stage II

Biomarkers: ER-positive

As of June 2026, Callie described survivorship after mastectomy, ACT chemotherapy, reconstruction, and hysterectomy for Stage IIB ER-positive IDC, with all cancer-directed treatment completed by the end of 2019.

The Patient StoryRead more →

Stage II BRCA1 Breast Cancer: Joy's Survivor Story

Patient Info: Joy R., Female | Stage II

Biomarkers: BRCA1 mutation

As of June 2026, Joy had no evidence of disease after chemotherapy, double mastectomy, and hysterectomy for Stage II breast cancer with a BRCA1 mutation, and had moved from 3-month to 6-month oncology monitoring.

The Patient StoryRead more →

Stage IV Ovarian Cancer First Found Through an Umbilical Metastasis

Patient Info: Anonymized, female, 60s | Stage IV

Biomarkers: WT1-positive; CK7-positive; CA-125 321 U/mL at diagnosis

Metastatic Site: umbilicus

After 9 months of bevacizumab maintenance, her clinical and imaging findings remained stable.

PubMed CentralRead more →

Eight years cancer-free after treatment for a rare ovarian Brenner tumor

Patient Info: Anonymized, Female, 50s | Stage I

Biomarkers: High Ki-67

At 8-year follow-up, surveillance showed no clinical or radiologic evidence of disease.

PubMed CentralRead more →

Stage IV Colorectal Cancer: Helen's Survivor Story

Patient Info: Helen, Female, 40s | Stage IV

Metastatic Site: Liver; pelvis

No active tumors / no evidence of disease after liver-directed treatment, liver surgery/ablation, colon resection, and hysterectomy, though she personally described herself as living with cancer and still planned cleanup treatment.

The Patient StoryRead more →

Early ovarian cancer found during care for Rosai-Dorfman disease

Patient Info: Anonymized, Female

After surgery for early ovarian cancer, she entered tumor-specific follow-up without adjuvant chemotherapy.

PubMed CentralRead more →

Ovarian Cancer: Hope's Patient Story

Patient Info: Hope Aguilar, female

More than 14 years after her December 2011 diagnosis, Hope is a survivor and advocate after initial treatment and a later ovarian-cancer recurrence.

Stage IV Colorectal Cancer: Alyssa's Patient Story

Patient Info: Alyssa Kelly, Female, Under 40 | Stage IV

Metastatic Site: Liver; lung

More than 4 years after pregnancy-associated Stage IV colorectal cancer, Alyssa was alive with her son, but after more than 1 year off chemotherapy she had several lung tumors, restarted chemotherapy, and was looking into clinical trials.

City of HopeRead more →

Stage II HR-Positive Breast Cancer: Sian's Survivor Story

Patient Info: Sian Bevans, Female, 50s | Stage II

Biomarkers: Triple-positive

Sian was 11 years past diagnosis, completed 10 years of maintenance medication in May 2025, and reported feeling more like herself; no recurrence was described.

Cleveland ClinicRead more →

Stage I HR-Positive Invasive Lobular Carcinoma: Erica's Survivor Story

Patient Info: Erica, Female, 40s | Stage I

Biomarkers: ER-positive; PR-positive; HER2-negative

As of December 2025, Erica had Stage IA ER-positive/PR-positive/HER2-negative ILC removed with negative lymph nodes, completed 16 rounds of radiation, and was focused on survivorship and advocacy.

Lobular Breast Cancer AllianceRead more →

Ovarian Cancer Surgery Complicated by Infective Endocarditis After Splenectomy

Patient Info: Anonymized, female, 50s

After ovarian-cancer surgery, she developed intestinal obstruction and infective endocarditis and later died from septicemia.

PubMed CentralRead more →

Ovarian Cancer Remission With Olaparib After Chemotherapy Intolerance

Patient Info: Anonymized, female, 50s | Stage III

Biomarkers: germline BRCA1 mutation

At 48 months, imaging showed complete remission and CA125 was normal while she continued reduced-dose olaparib.

PubMed CentralRead more →

Young Woman With Rare Small Cell Ovarian Cancer and Abdominal Recurrence

Patient Info: Anonymized, female, Under 40 | Stage III

Biomarkers: loss of SMARCA4 expression; retained SMARCB1 expression

The recurrent cancer continued to progress despite further chemotherapy, and she died at home 26 months after the initial diagnosis.

PubMed CentralRead more →

Stage II Triple-Negative Breast Cancer: Jennifer's Survivor Story

Patient Info: Jennifer Rancik, Female, Under 40 | Stage II

Biomarkers: BRCA1 mutation; triple-negative breast cancer

Jennifer entered remission in October 2017 after Stage II triple-negative breast cancer treatment and, as of October 2025, reported doing great and being off medications except occasional Zometa.

City of HopeRead more →

Rare Ovarian Neuroendocrine Cancer Treated With Surgery and Chemotherapy

Patient Info: Anonymized, female, 40s

Biomarkers: somatic BRCA2 mutation; MSI-H; high tumor mutational burden; germline BRCA2 negative

CT imaging and CA-125 follow-up showed no evidence of recurrence over 2 years.

PubMed CentralRead more →

Stage IIIB ascending colon cancer with later cervical and vaginal metastases, systemic nodal progression, and death

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: Primary colon cancer and vaginal/cervical metastasis both supported colorectal origin. MMR proteins were retained; HER2 0; Ki-67 high in metastasis.

Metastatic Site: cervix, vagina, rectal wall/serosa, systemic lymph…

After initial Stage IIIB ascending-colon cancer and later cervical/vaginal metastatic recurrence, CAPEOX was stopped because of cardiac toxicity; systemic lymph node metastases developed in early 2023, treatment was abandoned, and she died in April 2023.

PubMed CentralRead more →

Ovarian cancer treated with chemotherapy and repeat pelvic surgery after recurrence

Patient Info: Anonymized, Female, Under 40

She improved after the repeat pelvic surgery and postoperative care and was discharged home.

PubMed CentralRead more →

Stage IV Colorectal Cancer: Albita's Patient Story

Patient Info: Albita, Female, Under 40 | Stage IV

Biomarkers: Described as wild type; no hereditary genetic marker reported

Metastatic Site: liver

Albita had Stage IV colon cancer with liver metastases. As of April 2025, the only active cancer she described was still in the liver, with 3 spots remaining after chemotherapy, radiation, liver resection, hysterectomy/colon surgery, ileostomy, and ongoing/planned liver-directed treatment.

The Patient StoryRead more →